Close Menu

NEW YORK (GenomeWeb News) – Becton Dickinson said on Thursday it has entered into a five-year agreement for the creation of an unsecured revolving credit facility for up to $1.5 billion.

The facility, which expires in May 2017, provides BD with $1 billion of financing, as well as access to an additional $500 million of financing, subject to additional commitments by the lenders.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: transcriptomic and genomic analysis of prostate cancer by ancestry, genes linked to liver function in Korean cohort, and more.

British Columbia is incorporating genomics into its tracking of the ongoing COVID-19 outbreak, Business in Vancouver reports.

An analysis by the Personalized Medicine Coalition finds that about a quarter of new drugs approved in 2019 by the US Food and Drug Administration were personalized medicines.

The governor of New York has proposed a five-year plan to study the genomes of people with or who are at high risk of developing Alzheimer's disease.